MruucrcPcrBo sAPeBooxPanef,Er Poccnficxofi OcgePaqgn OEAEPAJIbHAfl CJIYXEA NO HAASOPY B COEPE 3,{PABOOXPAHEHng Pyxono4ureJlqM oPraHH3aIII4fi - (POG,qPABHA,qSOP) [poH3I]OAI4Tenefr JIeKapc'r'BeI{HLIX CrastlrcKat nn. 4, ctp. 1, Mocroa, 109074 cpeAcrB Tote$on: (495) 698 45 38;598 15 74

/f. //. .o' Ne /zu* lefJ f3 Pyrono4IareJl{M opraHla3allufr - I4MlIopTepoB neKapcTBeHHLIX cpeAc'fll HaNe 0r- Cy6:rertaM o6pauennfl neKapcrBeHHbIX Cpe/ICTI]
Peuteuue lro pe3ynbraraM 3KCleprI,I3bI KaqecTBa rreKapcTBeHHbIX CpeAcTB

q'ro Oe4epaltHarr cnyx6a no HaA3opy n csepe 3,{paBooxpaHeHnl HI.I0opMI4pye'r, llo pe3ynr,Ta.faM 3Koneprr43r,r KaqecrBa neKapcrBeHHbIX CpeACTts llpI4I'I{TO pelllel{I4e o coorBe.[crB1414 ycraHoBnel{I{bIM Tpe6oBa}II4tM KatIecrBa neKapcrl]eHHbIX cpe/Ic'fll'
[epeqLIcJIeHI ILIX B lrpI4JI OX{ eIIVrr4.

flpnroxeHl4e: Ha 3 l. tl I eKs.

Bpno pyKoBo/ll4rent [4.K.Eopsr.tr

f .B.l-anHoqxa 84995780 I 87  ftpn.;roNeHne K nucbMy Pocs4paeHaA3opa or6Zil6x, //a /Jf6/l KOTOpHX POCaApaBHaA3OpOM nprrHCTO PeuIeH{e O COOTBeTCTBI'III IIX Kaq€CTB'
cBeaefirr' o r€KepcTBe{H6rx cp€acTBax! rro peyn6TaTa]t lxcn€pTlt36l lclq€cTBa HOBJIEHHbIM HI{flM llpou:eo4are,rs CrpaHa np-na SrccneprHar opfaH143alrl4t Cepuu Hovep 3a4aHwfl Haulresogague Jlercapcreeu Hoe cPeAcrBo opfaH H3aIII4I4, npe4craeneureft o6Pa:qst JreKapcTBeH Hbtx cpeAcTB

PHHcy,rnH P, pacraoP Alr CAO "Har-(uoHarlbHble Poccl,rs Of EOY B fIO Pocctt ircrcui.r 0203 i 3 flpuxa: MocroecKIail uaYuHo- qeHrP uHrercuuft 100 ME/un 10ltl, SnotexHoJtolttH" yHnBepclrrer gpyN6u reppHropHanbHofo npaKrnqecKnfi HapoAoB I,lcn rtrare,r sHttfr opfaHa 6opr6sr c ry6epxYleson't Snaxourt (1), naurn KaproHHble rreHrp "I{eurp Poc:4panuaA3opa ro r. AenapTaMeHTa KOJIJIEKTllBHOIO Mocree H MocxoecKoft 3ApaBooxpaHeHLIs noJrt 30BaHHr (Hayvuo- o6nacru or 16.09.2013 ropoAa Mocrcest o6pa:oearersHst fi qeHrp)"
Ils828/ 13 Pr,rHcy:ruH@ HnX, cycneH3I4f, OAO "HaqproHuLIIbHbte Pocclzs O|6OY BflO Pocwtitcrcun 0304 1 3 flpura: MocxoecKHfi HaYuHo- 6lto.rexHonorHtl" yHHBepcHrer apyx6sr reppHTOpLIanbHoro npaKThqecKufr qeurP Anr noAKoxHofo BBeAeHHq un HapoAoB tr4cnsttarelesuft opfaHa 6ops6sr c ry6eprYne:ou 100 ME/vn, QlaxoHst 10 (l), naurn KaproHHble rIeHTp "l{eHrp Poc:4paeHaA3opa no r. AeIIaprai\,IeHTa KOJIJIEKTI4BHOIO MocKee H Mocxoecrcoft 3ApaBooxpaHeHnfi rroJt30BaHHx (Hayuuo- o6racrn or 16.09.2013 ropoAa Mocrcsrl o6pa:orarersH slft qenrp)"
Ns828/13 MocxoecxHil HaYuHo- flpora$aH@ HM, cycneu:ur Hoeo Hoplncx A/C flawax O|EOY B flO Poccu i.rcrcraia CS6C452 flprarca:
yHHBepcr4rer 4pyN6sr Teppl.rTopHaJIbHOro npaKTHqecKnI qeHrP aIfl noAKo)KHOfO BBeAeHHt HapoAoB Irlcnstrarelusrtft opraHa 6op16r,r ry6epxy,'resov 100 ME/rvrir l0 ltl, SlaroHst c (1), navrcn KaproHHble qeHrp "I{earp Poc:4paeHag3oPa lro r. AenapTaMeHra KOJIJICKTHBHOIO Mocxee w Mocxoecrofr 3ApaBooxpaHeH14q noJrb30BaHHr (Hayvno- oltacru or 16.09.2013 ropoAa Mocrert o6pa:oearelsHsrft ueurp)"
l\s828/ l3 Mocroecxuil uayvHo- Axrpanra4@ HM, pacreoP Hoso HopAlacrc A/C flauut OIBOY BflO Poccn ficrcui,t CS6D147 fIparca:
yHHBepcHrer gpyx6ul reppr4Top14aJIbHol-o npaKTI,rqecKnil Ileurp Alr l{HbeKltr,rnr 100 ME/u,r c ry6epry.ne:ov 10 urr, Slarcoust (1), navrcu HapoAoB I4cnurarelsnufi opraHa 6ops6sr KaproHHble r-(eHrp "I{eHrp Poc:npanuaA3opa no r. AeIIapTaMeHra KOJIIEKTI4BHOIO Mocrae u Mocrcoecrcoi 3ApaBOOxpaHeHHt noJIb3oBaH 14r (Hayu Ho- o6.;racrn or 1 6.09.20 1 3 fopoAa Mocxest o6pa:oearelsH srfi ueHrp)"
,r*e828/ l3  Hoso Hop:rrrcrc A/C fiauun OI-BOY BIIO Poc*tft crcuri cT60128 flpura: Mocxoecxt't it ua1'ut-lo- H oeo PanHA@ [Ie HS rr.;r,r.
pacrBop Ant BHyrpH BeHHOfo yHHBepcHrer 4pyN6sr TeppHTopna.i-lbHoro rrpaKTI4qecKnil ueHrP HapoAoB [4cn strarelss sr il opraHa 6ops6sr c ry6eprcY,re:ont H noAKoxHoro BBeAeHHfl 100 E[/ur 3 v,r, xaPlPu4xll ueHrp "l{eurp Pocs4paeHaA3oPa flo f. AenapTaMeHTa KOJI-UIeKTI4BHOfO Mocxee H MocxoecKoil 3ApaBooxpaHeHfifi (5). ynaxonxH sqeilxoeue nor'rb3oBaH14r (Hayv uo- o6racrn or 16.09.2013 ropoAa Mocxsrl KoHrypHbte (1). navrn KapToHHble o6pa:oearerrnslft qeHrp)"
"{e828l13 Arcrpanr.r4@ HM fleHQn:u, Hoso Hoprtucr A/C fianun OI-EOY BflO Poccn itcxuil cT60203 flpurca: fEV3 "Mopo3oBcKaq pacTBOp A,rs uHrerqnft yHHBepcHrer 4pyx6sr TepphTop14a"lbHoI-o AfE A3 ropoAa HapoAoB I4cnslrarelrHrtil opfaHa MocKBbt" 100 ME/ur 3 ur, xaPrPn4xn qeHrp "l{eurp Poc:gpaeuaA3opa no r. (5), ynaroercH gqeft Kosste KoHTypHbIe (l), navxa KOJIJICKTHBHOfO MoqlYs827/13 Xyr'.rynun@ HfIX, cycneH314,I Iw:rlu @paHc @paHqur O|6OY BflO PoccttVrcr (5), ynarcoerct{ qqefr xosste ueHrp "I{eurp Poc:4paeHaA3oPa no r.
KoHTypHbIe (l), navxn KOJ]JICKTHBHOIO Mocrcse u Mocrcoscrcoil noJrb3oBaHHr (HayvHo- o6racru or 15.09.2013 KapToHHble o6pa:onarelsHrtft qeHrp) "
N827/13 Xyrvra-rror@, pacrBop Arfl . w;r;tvt @paHc @paHqar OI-EOY BflO Poccnficxufi c1273444 flparca: fEV3 "Mopo3oBcKat yHHBepcr.rrer 4pyx6rr reppHTOp14anbHofo AfE A3 ropoAa nulerqnft 100 ME/un 3 ur, Kaprpr,tA)Kn (5), ynarcoerca HapoAoB 14cnstrarelsHttfr opraHa MocKBbr"
qeHrp "l{eurp Poc:4paeHaA3opa no r. sqeftKoeste xoHrYPnsre ( 1 ), KOJIJIEKTUBHOfO Mocrcse H Mocxoscrofi fiaqKI4 KaproHHLIe nonb3oBaHHr (HayvHo- o6racrH or 15.09.2013 o6pa:onare,rrHuft qeHrp)"
iVs827/13 Xy,r,rynnu@ P EfY jl -fl P, llutlu cDpaHc OpaHunr O|EOY BflO Poccn irct (5), ynaxoercH .sqefr rcoebte qeHTp "[eHrp Poc:4paeHaA3opa rto f.
Mocxee H Vocrcoecrcoil KoHTypHbre (l), naurcn KOIJICKTKBHOfO
KapToHHble rroJrb3oBaH14r (HayuHo- o6,racrn or 15.09.2013 o6pa:oearelsHstfi qeHrp)"
)rts827/ 1 3  Hoeo Hopancr A/C @f6OY BflO PoccraficrnI cT60 1 28 l-EV3 "Mopo30BcKafl H oeo Panhrl@ fleHQu:r-i, flpurca: yHHBepcr4rer 4pyx6u I-E A3 ropola pacrBop Anfl BHyrpHBeH Hofo Tepp I,tToP Har-l !' HO ro HapoAoB 14cnttrarelsHutil MocKBbt" u noAKO)KHOTO BBeAeHHtl opfaHa rreHrp "l-{eurp 100 E!/r',u 3 u,r, rcaPrPn4xu Poc:gpaeHaA3oPa no r. KOJIr-leKTH BHOfo (5), ynarcoercn qqefi roelte Mocree H Mocrcoecxofi noirb3oBaHHr (HayvHo- KoHrypHbIe (1), navxn o6lacru or 15.09.2013 o6pa:oaarerssltft qeHrP) "
KapToHHble Ns827113

Министерство здравоохранения Российской Федерации
ФЕДЕРАЛЬНАЯ СЛУЖБА ПО НАДЗОРУ Г. |
В СФЕРЕ ЗДРАВООХРАНЕНИЯ
(РОСЗДРАВНАДЗОР) Руководителям организаций-
производителей лекарственных Славянская пл. 4, стр. 1, Москва, 109074 средств Телефон: (495) 698 45 38; 698 15 74
La V7. РЗ № (Pt-£3 57/5 Руководителям организаций-
импортеров лекарственных средств На № от
Г. | Субъектам обращения лекарственных средств Решение по результатам экспертизы качества лекарственных средств
Федеральная служба по надзору в сфере здравоохранения информирует, что по результатам экспертизы качества лекарственных средств принято решение о соответствии установленным требованиям качества лекарственных средств, перечисленных в приложении.

Приложение: на 3 л. в 1 экз.

Врио руководителя у И.К.Борзик
Г.В.Ганночка 84995780187